| UniProt/SwissProt ID: | CHK2_HUMAN |
| Description: | checkpoint kinase 2 [Source:HGNC Symbol;Acc:16627] |
| Location: | chr22 q12.1 |
| Node attribute: | Enzyme(source); substrate; kinase; Enzyme(target) |
| Phosphorylation site |
| Position | PhosphoPeptide | Catalytic kinase | Source |
|---|---|---|---|
| S41 | QGISSsSTSTM | DUF966 | PhosphoSitePlus |
| S516 | VLAQPsTSRKR | PhosphoSitePlus | |
| T225 | YIMSKtLGSGA | Pkinase | PhosphoSitePlus |
| T430 | RTLCGtPTYLA | CHEK2 | HPRD |
| S39 | QSQGIsSSSTS | DUF966 | PhosphoSitePlus |
| S559 | VLAQPsTSRKR | CHEK2 | HPRD |
| S12 | VEAQQsHGSSA | DUF966 | PhosphoSitePlus |
| S44 | SSSSTsTMPNS | DUF966 | PhosphoSitePlus |
| S62 | SGTLSsLETVS | DUF966 | PhosphoSitePlus |
| S28 | GSVTQsQGSSS | ATM | HPRD; phosphoELM; RegPhos |
| S28 | GSVTQsQGSSS | ATR | HPRD; RegPhos |
| S379 | ILGETsLMRTL | Pkinase | PhosphoSitePlus |
| S456 | VWAEVsEKALD | Pkinase | PhosphoSitePlus |
| S35 | GSSSQsQGISS | ATM | HPRD; phosphoELM; RegPhos |
| S35 | GSSSQsQGISS | ATR | HPRD; RegPhos |
| S40 | SQGISsSSTST | DUF966 | PhosphoSitePlus |
| T68 | LETVStQELYS | CHK2 | phosphoELM; RegPhos |
| T68 | LETVStQELYS | PLK1 | HPRD; phosphoELM; RegPhos |
| T68 | LETVStQELYS | PLK3 | HPRD; RegPhos |
| T383 | TSLMRtLCGTP | CHK2 | phosphoELM; RegPhos |
| S35 | GSSSQsQGISS | DUF966 | PhosphoSitePlus |
| S19 | GSSACsQPHGS | DUF966 | PhosphoSitePlus |
| T65 | LSSLEtVSTQE | DUF966 | PhosphoSitePlus |
| T387 | RTLCGtPTYLA | CHEK2 | HPRD |
| T68 | LETVStQELYS | CHEK2 | HPRD |
| T432 | FSEHRtQVSLK | Pkinase | PhosphoSitePlus |
| T383 | TSLMRtLCGTP | Pkinase | PhosphoSitePlus |
| T517 | LAQPStSRKRP | PhosphoSitePlus | |
| S24 | SQPHGsVTQSQ | DUF966 | PhosphoSitePlus |
| T43 | ISSSStSTMPN | DUF966 | PhosphoSitePlus |
| T68 | LETVStQELYS | ATM | HPRD; phosphoELM; RegPhos |
| S372 | TDFGHsKILGE | Pkinase | PhosphoSitePlus |
| S33 | SQGSSsQSQGI | ATM | HPRD; phosphoELM; RegPhos |
| S120 | FGRDKsCEYCF | FHA | PhosphoSitePlus |
| S19 | GSSACsQPHGS | ATR | HPRD; RegPhos |
| S19 | GSSACsQPHGS | ATM | HPRD; phosphoELM; RegPhos |
| S456 | VWAEVsEKALD | phosphoELM | |
| T378 | KILGEtSLMRT | Pkinase | PhosphoSitePlus |
| S55 | SQSSHsSSGTL | DUF966 | PhosphoSitePlus |
| Y390 | CGTPTyLAPEV | Pkinase | PhosphoSitePlus |
| S164 | YIEDHsGNGTF | FHA | PhosphoSitePlus |
| S33 | SQGSSsQSQGI | DUF966 | PhosphoSitePlus |
| T387 | RTLCGtPTYLA | CHK2 | phosphoELM; RegPhos |
| T26 | PHGSVtQSQGS | PLK1 | HPRD; phosphoELM; RegPhos |
| S73 | TQELYsIPEDQ | DUF966 | PhosphoSitePlus |
| T68 | LETVStQELYS | TTK | phosphoELM |
| S15 | QQSHGsSACSQ | DUF966 | PhosphoSitePlus |
| S28 | GSVTQsQGSSS | DUF966 | PhosphoSitePlus |
| S210 | TVDDQsVYPKA | PhosphoSitePlus | |
| S33 | SQGSSsQSQGI | ATR | HPRD; RegPhos |
| T45 | SSSTStMPNSS | DUF966 | PhosphoSitePlus |
| S260 | KFAIGsAREAD | Pkinase | PhosphoSitePlus |
| S50 | TMPNSsQSSHS | ATR | HPRD; RegPhos |
| S50 | TMPNSsQSSHS | ATM | HPRD; phosphoELM; RegPhos |
| T26 | PHGSVtQSQGS | ATR | HPRD; RegPhos |
| T26 | PHGSVtQSQGS | ATM | HPRD; phosphoELM; RegPhos |
| S42 | GISSSsTSTMP | DUF966 | PhosphoSitePlus |
| S435 | HRTQVsLKDQI | Pkinase | PhosphoSitePlus |
| T389 | LCGTPtYLAPE | Pkinase | PhosphoSitePlus |
| S50 | TMPNSsQSSHS | DUF966 | PhosphoSitePlus |
| S67 | SLETVsTQELY | DUF966 | PhosphoSitePlus |
| S52 | PNSSQsSHSSS | DUF966 | PhosphoSitePlus |
| T426 | TSLMRtLCGTP | CHEK2 | HPRD |
| T68 | LETVStQELYS | DUF966 | PhosphoSitePlus |
| T68 | LETVStQELYS | ZAK | RegPhos |
| T383 | TSLMRtLCGTP | CHEK2 | HPRD |
| S487 | VLAQPsTSRKR | CHEK2 | HPRD |
| T354 | TSLMRtLCGTP | CHEK2 | HPRD |
| S140 | KYRTYsKKHFR | FHA | PhosphoSitePlus |
| S516 | VLAQPsTSRKR | CHEK2 | HPRD |
| T358 | RTLCGtPTYLA | CHEK2 | HPRD |
| S516 | VLAQPsTSRKR | CHK2 | phosphoELM; RegPhos |
| T205 | VFFDLtVDDQS | PhosphoSitePlus | |
| T387 | RTLCGtPTYLA | Pkinase | PhosphoSitePlus |
| T26 | PHGSVtQSQGS | DUF966 | PhosphoSitePlus |
| Dephosphorylation site |
| CHK2_HUMAN do not have dephosphorylation site. |
| Mutation site |
| Ensembl ID | Variation | Source | Cancer name | Pubmed |
|---|---|---|---|---|
| ENSP00000329178 | R145P | HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | T323P | HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | E64K | HPI | Prostate Cancer | 12533788 |
| ENSP00000329178 | T59K | HPI | Other Cancer | 12052256 |
| ENSP00000329178 | A17S | OMIM, HPI | Sarcoma | 11746983 |
| ENSP00000385747 | T476K | HPI | Prostate Cancer | 12533788 |
| ENSP00000329178 | S428F | OMIM | Breast Cancer | 15649950 |
| ENSP00000329178 | I157T | OMIM | Colorectal Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000329178 | I157T | OMIM | Prostate Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000329178 | E239K | OMIM, HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | I157T | OMIM | Other Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000386087 | T59K | HPI | Other Cancer | 12052256 |
| ENSP00000329178 | R318H | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | E239K | OMIM, HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | I157T | OMIM | Colorectal Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000385747 | G167R | HPI | Prostate Cancer | 12533788 |
| ENSP00000329178 | I157T | OMIM | Other Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000329178 | R180H | OMIM, HPI | Prostate Cancer | 12533788, 12454775 12533788 15818573 |
| ENSP00000329178 | G167R | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | G167R | HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | R145P | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | R145P | HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | S428F | OMIM | Breast Cancer | 15649950 |
| ENSP00000386087 | I157T | OMIM | Other Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000385747 | I251F | HPI | Prostate Cancer | 12533788 |
| ENSP00000329178 | T323P | HPI | Prostate Cancer | 12533788 |
| ENSP00000329178 | R181H | OMIM, HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | I157T | OMIM | Prostate Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000385747 | R318H | HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | Y327C | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | R181H | OMIM, HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | R180H | OMIM, HPI | Prostate Cancer | 12533788, 12454775 12533788 15818573 |
| ENSP00000385747 | A17S | OMIM, HPI | Sarcoma | 11746983 |
| ENSP00000329178 | Y327C | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | T476K | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | I251F | HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | R181H | OMIM, HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | I157T | OMIM | Colorectal Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000329178 | I251F | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | A17S | OMIM, HPI | Sarcoma | 11746983 |
| ENSP00000386087 | T323P | HPI | Prostate Cancer | 12533788 |
| ENSP00000329178 | P85L | OMIM, HPI | Sarcoma | 11746983, 11746983 15649950 17721994 |
| ENSP00000386087 | Y327C | HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | E239K | OMIM, HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | I157T | OMIM | Prostate Cancer | 10617473 12533788 15239132 15492928 16816021 17085682 |
| ENSP00000385747 | P85L | OMIM, HPI | Sarcoma | 11746983, 11746983 15649950 17721994 |
| ENSP00000329178 | T476K | HPI | Prostate Cancer | 12533788 |
| ENSP00000385747 | T59K | HPI | Other Cancer | 12052256 |
| ENSP00000386087 | R318H | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | E64K | HPI | Prostate Cancer | 12533788 |
| ENSP00000329178 | E64K | HPI | Prostate Cancer | 12533788 |
| ENSP00000386087 | R180H | OMIM, HPI | Prostate Cancer | 12533788, 12454775 12533788 15818573 |
| ENSP00000386087 | P85L | OMIM, HPI | Sarcoma | 11746983, 11746983 15649950 17721994 |
| ENSP00000386087 | S428F | OMIM | Breast Cancer | 15649950 |
| Differential expressed protein |
| CHK2_HUMAN is not differential expressed protein. |
| Hyperphosphorylation site |
| Site | Motif | Peptide | Cancer name | Pubmed | Source |
|---|---|---|---|---|---|
| T68 | DUF966 | SSLETVStQELYSIP | small-cell lung cancer | 16705183 | PhosphoSitePlus |
| T68 | DUF966 | SSLETVStQELYSIP | bladder cancer | 15361851 | PhosphoSitePlus |
| Direct Interaction Pair |
| Source | Target | Relationship | Resource |
|---|---|---|---|
| CHK2_HUMAN | MDM4_HUMAN | kinase -> substrate | HPRD |
| MARK3_HUMAN | CHK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | E2AK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | MPIP1_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
| ATR_HUMAN | CHK2_HUMAN | kinase -> substrate | RegPhos |
| CHK2_HUMAN | SMPX_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | AIRE_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CDKL5_HUMAN | CHK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | MLX_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | MDM2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| AURKB_HUMAN | CHK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | MTA1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | LZTS1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | SOX10_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| MLTK_HUMAN | CHK2_HUMAN | kinase -> substrate | RegPhos |
| PLK3_HUMAN | CHK2_HUMAN | kinase -> substrate | HPRD; RegPhos |
| CHK2_HUMAN | OTU7B_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | CHK2_HUMAN | kinase -> substrate | RegPhos |
| CHK2_HUMAN | ZYX_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | P53_HUMAN | kinase -> substrate | KEGG; RegPhos; Robert H Newman (2013) |
| JAK2_HUMAN | CHK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | E2F1_HUMAN | kinase -> substrate | HPRD; RegPhos; Robert H Newman (2013) |
| CHK2_HUMAN | BRCA1_HUMAN | kinase -> substrate | HPRD; RegPhos; Robert H Newman (2013) |
| CHK2_HUMAN | IASPP_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | MPIP3_HUMAN | kinase -> substrate | HPRD; RegPhos; Robert H Newman (2013) |
| CHK2_HUMAN | LRIG1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | HCLS1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| PLK1_HUMAN | CHK2_HUMAN | kinase -> substrate | RegPhos; Robert H Newman (2013) |
| CDK9_HUMAN | CHK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| ATM_HUMAN | CHK2_HUMAN | kinase -> substrate | RegPhos |
| E2AK2_HUMAN | CHK2_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | MRF_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | AATF_HUMAN | kinase -> substrate | HPRD |
| CHK2_HUMAN | NDF1_HUMAN | kinase -> substrate | Robert H Newman (2013) |
| CHK2_HUMAN | DGKA_HUMAN | enzyme catalysis | KEGG |
| CDIPT_HUMAN | CHK2_HUMAN | enzyme catalysis | KEGG |
| Function Annotation |
| KEGG Pathway |
| KEGG ID | Pathway |
|---|---|
| hsa04110 | Cell cycle |
| hsa04115 | p53 signaling pathway |
| hsa05166 | HTLV-I infection |
| Gene Ontology |
| GO ID | GO_Term | Evidence | Ontology |
|---|---|---|---|
| GO:0016772 | transferase activity, transferring phosphorus-cont | IEA | molecular_function |
| GO:0000077 | DNA damage checkpoint | IEA | biological_process |
| GO:0046872 | metal ion binding | IEA | molecular_function |
| GO:0045893 | positive regulation of transcription, DNA-dependen | IDA | biological_process |
| GO:0006915 | apoptotic process | IEA | biological_process |
| GO:0004674 | protein serine/threonine kinase activity | IEA | molecular_function |
| GO:0042803 | protein homodimerization activity | IDA | molecular_function |
| GO:0005515 | protein binding | IPI | molecular_function |
| GO:0000086 | G2/M transition of mitotic cell cycle | IMP | biological_process |
| GO:0008630 | intrinsic apoptotic signaling pathway in response | IDA | biological_process |
| GO:0090307 | spindle assembly involved in mitosis | IMP | biological_process |
| GO:0004674 | protein serine/threonine kinase activity | IDA | molecular_function |
| GO:0016605 | PML body | IDA | cellular_component |
| GO:0031625 | ubiquitin protein ligase binding | IPI | molecular_function |
| GO:0016301 | kinase activity | IEA | molecular_function |
| GO:0006468 | protein phosphorylation | IEA | biological_process |
| GO:0090399 | replicative senescence | NAS | biological_process |
| GO:0046777 | protein autophosphorylation | IDA | biological_process |
| GO:0044257 | cellular protein catabolic process | IMP | biological_process |
| GO:0004672 | protein kinase activity | IEA | molecular_function |
| GO:0005524 | ATP binding | IEA | molecular_function |
| GO:0005654 | nucleoplasm | TAS | cellular_component |
| GO:0042770 | signal transduction in response to DNA damage | IEA | biological_process |
| GO:0072428 | signal transduction involved in intra-S DNA damage | IMP | biological_process |
| GO:0042770 | signal transduction in response to DNA damage | IDA | biological_process |
| GO:0006351 | transcription, DNA-dependent | IEA | biological_process |
| GO:0010332 | response to gamma radiation | IEA | biological_process |
| GO:0051301 | cell division | IEA | biological_process |
| GO:0004713 | protein tyrosine kinase activity | IEA | molecular_function |
| GO:0006974 | response to DNA damage stimulus | IMP | biological_process |
| GO:0006302 | double-strand break repair | IMP | biological_process |
| GO:0006355 | regulation of transcription, DNA-dependent | IDA | biological_process |
| GO:0000781 | chromosome, telomeric region | IDA | cellular_component |
| GO:0000077 | DNA damage checkpoint | TAS | biological_process |
| GO:0042176 | regulation of protein catabolic process | IMP | biological_process |
| GO:0000075 | cell cycle checkpoint | TAS | biological_process |
| GO:0019901 | protein kinase binding | IPI | molecular_function |
| GO:0006975 | DNA damage induced protein phosphorylation | IMP | biological_process |